Aimei Health Technology Co., Ltd Ordinary Share (AFJK)
NASDAQ: AFJK · IEX Real-Time Price · USD
10.38
+0.02 (0.19%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd Ordinary Share
Country | NY |
Founded | 2023 |
IPO Date | Dec 4, 2023 |
Industry | Shell Companies |
Sector | Financials |
CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street, Suite 3001 New York, New York 10022 United States | |
Phone | 34 678 035200 |
Stock Details
Ticker Symbol | AFJK |
Exchange | NASDAQ |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0001979005 |
SIC Code | 6770 |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 20, 2024 | 8-K | Current Report |
May 13, 2024 | 10-Q | Quarterly Report |
Apr 19, 2024 | 8-K | Current Report |
Apr 9, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Mar 25, 2024 | 10-K | Annual Report |
Mar 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 2, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |